LoadingLoadingLoadingThe quick read
Latest quote·Oct 16
Net selling: insiders sold $4.3M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $1K to $15K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNet selling: insiders sold $4.3M and bought $0 of MMM stock on the open market in the 90 days to Oct 18, 2026, according to SEC Form 4 filings. The largest was Banovetz, John Patrick (Executive Vice President), who sold $1.3M. The latest filing was on Aug 6, 2026.
Rep. Josh Gottheimer (D) sold $1K to $15K on Apr 28, 2026, disclosed 21 days later. In total, 1 member disclosed 1 MMM trade with trade dates in the last 180 days, filed a median 21 days after trading.
This summary uses filings available on Oct 18, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net selling.
Buys/Adds (2)
Balyasny
$372.4M
added
Point72
$91.6M
bought
Sells/Trims (1)
Man Group
$69.7M
trimmed
Buys (1)
Sells (2)
No tracked top-trader positions in MMM right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Jul 21, 2026
Financial period
Q2 2026
Adjusted EPS
$2.25 expected
Revenue
No comparable estimate
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 21, 2026 | $2.40 / $2.25Yahoo Finance | +6.84% beat | $6.50B / Unavailable | Unavailable |
| Mar 31, 2026 | Apr 21, 2026 | $2.14 / $1.98Yahoo Finance | +7.88% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Jan 20, 2026 | $1.83 / $1.80Yahoo Finance | +1.79% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 21, 2025 | $2.19 / $2.07Yahoo Finance | +5.60% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 18, 2025 | $2.16 / $2.01Alpha Vantage | +7.46% beat | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 22, 2025 | $1.88 / $1.77Alpha Vantage | +6.21% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Jan 21, 2025 | $1.68 / $1.54Alpha Vantage | +9.09% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 22, 2024 | $1.98 / $1.90Alpha Vantage | +4.21% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 17, 2026
EPS expected
$2.35 to $2.45
Revenue expected
12 analysts
Last 30 days
Analysts raising estimates
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $6.52B | $6.13B | $6.03B | $6.50B |
| Cost of what it sold | $3.79B | $4.08B | $3.57B | $3.82B |
| Gross profit | $2.73B | $2.06B | $2.46B | $2.68B |
| What it spent | ||||
| Research and development | $297.0M | $299.0M | $308.0M | $302.0M |
| Sales and admin | $820.0M | $965.0M | $744.0M | $1.06B |
| Other operating costs | — | — | — | $336.0M |
| Total operating expenses | $1.12B | $1.26B | $1.06B | $1.70B |
| What was left | ||||
| Operating profit | $1.61B | $794.0M | $1.40B | $984.0M |
| Interest on debt | $232.0M | $222.0M | $214.0M | $202.0M |
| Profit before tax | $1.15B | $758.0M | $878.0M | $1.12B |
| Tax | $308.0M | $185.0M | $221.0M | $183.0M |
| Net profit | $834.0M | $577.0M | $653.0M | $933.0M |
| EBITDA | $1.68B | $1.19B | $1.47B | $1.46B |
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bullish
3M lays out 'attack' on Commonwealth's $2 billion PFAS lawsuit
BearishOct 163M to argue Australia's $1.4 billion 'forever chemicals' lawsuit legally flawed, court hears
BearishOct 163M to Argue Australia's $1.4 Billion 'Forever Chemicals' Lawsuit Legally Flawed, Court Hears
BearishOct 16FactSet Research Systems Inc. stock outperforms competitors on strong trading day
Leans bullishOct 15Welltower Inc. stock outperforms competitors on strong trading day
Leans bullishOct 15INmune Bio stock sits 36.15 percent below its Nasdaq high
NeutralOct 15Barclays cuts target for Badger Meter stock to USD 111.00
NeutralOct 15Northland cuts target to USD 16.00 for Matrix Service stock
NeutralOct 1531 macro signals shaping MMM right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
